Recent News

• 09.22.2026 - Final Report - India Cohort Analysis: A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Given in a Series of 3 Infant Doses and 1 Toddler Dose in Infants in India and Taiwan
• 09.21.2026 - A Phase 1/2 Randomized, Observer-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Varicella Zoster Virus in Healthy Individuals Substudy A Supplemental CSR – Final Phase 1 Analysis
• 09.14.2026 - TwoStep Therapeutics
• 08.19.2026 - Vaccine Company
• 08.13.2026 - Oblenio Bio
• 08.13.2026 - An Interventional, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rimegepant for Migraine Prevention in Chinese Participants
• 07.15.2026 - A PHASE 1/2, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS
• 06.26.2026 - An Interventional, Open-Label, Randomized, Multicenter, Phase 2 Study of PF-07220060 Plus Letrozole Compared to Letrozole Alone in Postmenopausal Women 18 Years or Older With Hormone Receptor-Positive, HER2-Negative Breast Cancer in The Neoadjuvant Settin
• 06.10.2026 - Final Report: A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Pregnant Participants Living with HIV and Their Inf
• 06.10.2026 - Final Report: A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Pregnant Participants Living with HIV and Their Inf

Recent Filings

• 09.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.31.2026 - N-PX Annual Report of proxy voting record of management investment companies
• 08.28.2026 - 3 Initial statement of beneficial ownership of securities
• 08.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2026 - 13F-HR Quarterly report filed by institutional managers, Holdings
• 08.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2026 - 4 Statement of changes in beneficial ownership of securities